Keyphrases
Breast Cancer
88%
Tumor
73%
Breast Cancer Susceptibility Gene 1 (BRCA1)
70%
In Cancer
31%
Comprehensive Genomic Profiling
23%
DNA Damage
22%
Triple-negative Breast Cancer
21%
PALB2
21%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
DNA Damage Response
19%
Clear Cell Renal Cell Carcinoma (ccRCC)
19%
Tumorigenesis
17%
Programmed Death-ligand 1 (PD-L1)
17%
Genetic Modification
17%
Basal-like
17%
Immune Checkpoint Blockade
16%
Inactive X Chromosome
15%
Ductal Carcinoma in Situ
15%
PARP Inhibitor (PARPi)
14%
53BP1
14%
Autophagy
14%
Breast Tumor
14%
Next-generation Sequencing
14%
Breast Cancer Patients
13%
BRCA2
13%
Invasive Ductal Carcinoma
13%
Estrogen Receptor
13%
Prostate Cancer
13%
Targeted Therapy
13%
Breast Cancer Subtypes
12%
Clinical Trials
12%
Ovarian Cancer
12%
Estrogen Receptor-positive Breast Cancer
12%
Lymphocytes
12%
HER2+
12%
Overexpression
12%
Genomic Instability
12%
Mutational Burden
12%
Endogenous Retrovirus
12%
Cancer Genome Atlas
12%
Loss of Heterozygosity
11%
Invasive Breast Cancer
11%
Cancer Types
11%
Human Cancer
11%
Gene Expression
11%
Metabotropic Glutamate Receptor
11%
DNA Repair
10%
Chemotherapy
10%
Mutational Landscape
10%
Whole Slide Image
10%
Biochemistry, Genetics and Molecular Biology
BRCA1
65%
Genomics
60%
Estrogen Receptor
38%
DNA Repair
34%
Immune Checkpoints
32%
Carcinogenesis
31%
P53
31%
Cancer Cell
27%
DNA Damage Response
25%
Gene Expression
22%
PALB2
21%
X Chromosome
20%
DNA Damage
20%
Immunity
20%
RNA
17%
Phosphotransferase
16%
Kinase
16%
Autophagy
16%
Poly ADP Ribose Polymerase
15%
Oncogene
15%
Endogenous Retrovirus
15%
Genetics
14%
Insulin Release
14%
Homologous Recombination
14%
Clinical Trial
14%
Genome Instability
13%
Microarrays
12%
Mouse Mutant
12%
Synapsin I
11%
BRCA2
11%
T Cell
11%
Microsatellite
10%
Loss of Heterozygosity
10%
Progesterone Receptor
10%
Binding Protein
10%
Germline
10%
Germ Cell
10%
Next Generation Sequencing
10%
Protein Kinase C
10%
Epidermal Growth Factor Receptor
9%
Exon
9%
PD-L1
9%
Mouse Model
8%
Tumor Progression
8%
Messenger RNA
8%
Mitogen-Activated Protein Kinase
7%
Tumor Suppressor Protein
7%
Drug Resistance
7%
Principal Component Analysis
7%
Digital Pathology
7%
Medicine and Dentistry
Neoplasm
100%
Breast Cancer
97%
Malignant Neoplasm
64%
Disease
31%
Biological Marker
28%
Breast Tumor
23%
Estrogen Receptor
22%
BRCA1
21%
Histopathology
20%
Clear Cell Renal Cell Carcinoma
19%
Clinical Trial
18%
Immunotherapy
17%
Immunity
17%
Gene Expression
15%
Next Generation Sequencing
13%
Recurrent Disease
13%
Triple Negative Breast Cancer
12%
Autophagy
12%
Lymphocyte
12%
Targeted Therapy
12%
Lymphocytic Infiltration
11%
Metastatic Carcinoma
11%
Endogenous Retrovirus
10%
Epidermal Growth Factor Receptor 2
10%
Gamma Urogastrone
10%
Protein P53
10%
PARP Inhibitor
10%
DNA Repair
10%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
10%
Cancer Cell
10%
Phosphotransferase
10%
Tumor Microenvironment
9%
Solid Malignant Neoplasm
9%
Prostate Cancer
9%
Immune Checkpoint Blockade
9%
Haematoxylin
9%
Immune Response
8%
Cancer Therapy
8%
Carcinogenesis
8%
Overall Survival
8%
T Cell
8%
Personalized Medicine
8%
Basal Like Breast Cancer
7%
Eosin
7%
Carcinoma
7%
Oncogene
7%
Cancer Diagnosis
7%
Pembrolizumab
7%
Uterine Cancer
7%
Metabotropic Receptor 1
6%